Authorized Generic Drugs: Short and Long-Term Competitive Effects - Couverture rigide

Couverture rigide

ISBN 10 : 1622570758 ISBN 13 : 9781622570751

Editeur : Nova Science Publishers Inc, 2012

Synopsis

Rising health care costs have for many years focused congressional attention upon the development and availability of prescription drugs. Recently, the presence of "authorised generic" pharmaceuticals in the drug marketplace has been the subject of congressional concern. An "authorised generic" is a pharmaceutical that is marketed by or on behalf of a brand-named drug company, but is sold under a generic name. The brand-name firm may distribute the drug under its own auspices or via a license to a generic drug company. The price of this "authorised copy" is ordinarily lower than that of the brand-name drug. Some sources refer to authorised generics as "branded," "flanking," or "pseudo" generics." This book presents an analysis of the innovation and public health issues relating to authorised generic drugs beginning with a review of the procedures through which independent generic drug companies receive government permission to market their products and resolve patent disputes with brand-name firms and consumer welfare.

Détails de l'édition

• Éditeur: Nova Science Publishers Inc
• Date d'édition: 2012
• Langue: anglais
• ISBN 10: 1622570758
• ISBN 13: 9781622570751
• Reliure: Relié
• Numéro d'édition: 1
• Nombre de pages: 216
• Éditeur: Nelson Edward R, Wright Jerry G
• Coordonnées du fabricant: non disponible
• Personne responsable: non disponible